[go: up one dir, main page]

PL3018147T3 - Siarczanowany polisacharyd poli(kwasu gulonowego) lub jego sól farmaceutyczna, sposób ich wytwarzania i ich zastosowanie - Google Patents

Siarczanowany polisacharyd poli(kwasu gulonowego) lub jego sól farmaceutyczna, sposób ich wytwarzania i ich zastosowanie

Info

Publication number
PL3018147T3
PL3018147T3 PL14819337T PL14819337T PL3018147T3 PL 3018147 T3 PL3018147 T3 PL 3018147T3 PL 14819337 T PL14819337 T PL 14819337T PL 14819337 T PL14819337 T PL 14819337T PL 3018147 T3 PL3018147 T3 PL 3018147T3
Authority
PL
Poland
Prior art keywords
polyachacharide
sulphate
poly
manufacture
manner
Prior art date
Application number
PL14819337T
Other languages
English (en)
Inventor
Jian Ding
Jing AI
Yi Chen
Xun HUANG
Original Assignee
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute Of Materia Medica Chinese Academy Of Sciences filed Critical Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
Publication of PL3018147T3 publication Critical patent/PL3018147T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL14819337T 2013-07-02 2014-07-02 Siarczanowany polisacharyd poli(kwasu gulonowego) lub jego sól farmaceutyczna, sposób ich wytwarzania i ich zastosowanie PL3018147T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310275323.7A CN104277130A (zh) 2013-07-02 2013-07-02 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
PCT/CN2014/081472 WO2015000411A1 (zh) 2013-07-02 2014-07-02 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
EP14819337.8A EP3018147B1 (en) 2013-07-02 2014-07-02 Sulfated polygulonic acid polysaccharide or pharmaceutical salt thereof, preparation method therefor and use thereof

Publications (1)

Publication Number Publication Date
PL3018147T3 true PL3018147T3 (pl) 2018-10-31

Family

ID=52143111

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14819337T PL3018147T3 (pl) 2013-07-02 2014-07-02 Siarczanowany polisacharyd poli(kwasu gulonowego) lub jego sól farmaceutyczna, sposób ich wytwarzania i ich zastosowanie

Country Status (19)

Country Link
US (1) US10058566B2 (pl)
EP (1) EP3018147B1 (pl)
JP (2) JP6757249B2 (pl)
KR (1) KR102258569B1 (pl)
CN (2) CN104277130A (pl)
AU (1) AU2014286711B2 (pl)
BR (1) BR112015032849B1 (pl)
CA (1) CA2916749C (pl)
DK (1) DK3018147T3 (pl)
EA (1) EA028655B1 (pl)
ES (1) ES2674976T3 (pl)
HU (1) HUE038981T2 (pl)
MX (1) MX373099B (pl)
PL (1) PL3018147T3 (pl)
PT (1) PT3018147T (pl)
SG (1) SG11201510717SA (pl)
TR (1) TR201809674T4 (pl)
WO (1) WO2015000411A1 (pl)
ZA (1) ZA201509353B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
CN107904240A (zh) * 2017-12-04 2018-04-13 辽东学院 一种抗肝癌细胞转移的抑制剂组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
JPH0625304A (ja) 1992-07-06 1994-02-01 Higeta Shoyu Co Ltd ガラクトサミン重合体硫酸化物及び該物質を 含有する抗ウイルス剤
CN1132209A (zh) 1995-03-27 1996-10-02 青岛海洋大学 一种新药多聚甘露糖醛酸硫酸盐
GB2317182B (en) 1996-09-11 2000-11-01 Johnson & Johnson Medical Sulfated polysaccharides and uses thereof in medical treatment
CN1473836A (zh) * 2003-08-04 2004-02-11 中国海洋大学 还原端1位为羧基的古罗糖醛酸寡糖及其衍生物
CN1213071C (zh) * 2003-11-25 2005-08-03 中国海洋大学 一种古糖酯及其制备方法和应用
JP4897310B2 (ja) 2006-02-28 2012-03-14 理研食品株式会社 L−グルロン酸金属塩又はd−マンヌロン酸金属塩の製造方法
JP2008027767A (ja) 2006-07-21 2008-02-07 Aomori Prefecture 固体高分子電解質膜及び燃料電池
CN101691410B (zh) 2009-09-18 2011-12-28 中国海洋大学 一种具有防治胰岛素抵抗作用的海洋寡糖铬配合物
CN102892421A (zh) 2010-03-10 2013-01-23 伊诺沃生物公司 用于治疗代谢病症的包含葡甘露聚糖、黄原胶和藻酸盐的食物
CN102743409B (zh) 2012-06-18 2013-11-20 中国海洋大学 聚甘露糖醛酸丙酯硫酸盐在制备抗甲型h1n1流感病毒药物中的应用
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途

Also Published As

Publication number Publication date
JP2016523301A (ja) 2016-08-08
KR102258569B1 (ko) 2021-05-28
CN105358582B (zh) 2018-09-21
EP3018147B1 (en) 2018-05-23
ZA201509353B (en) 2017-08-30
CA2916749A1 (en) 2015-01-08
ES2674976T3 (es) 2018-07-05
MX2016000043A (es) 2016-05-31
CN104277130A (zh) 2015-01-14
CN105358582A (zh) 2016-02-24
AU2014286711A1 (en) 2016-02-04
EP3018147A4 (en) 2017-04-05
HK1220984A1 (zh) 2017-05-19
KR20160029817A (ko) 2016-03-15
WO2015000411A1 (zh) 2015-01-08
JP6772318B2 (ja) 2020-10-21
JP6757249B2 (ja) 2020-09-16
EA028655B1 (ru) 2017-12-29
HUE038981T2 (hu) 2018-12-28
AU2014286711B2 (en) 2018-05-10
US20160367591A1 (en) 2016-12-22
EP3018147A1 (en) 2016-05-11
MX373099B (es) 2020-03-31
CA2916749C (en) 2021-03-09
BR112015032849A2 (pt) 2020-05-12
DK3018147T3 (en) 2018-07-23
PT3018147T (pt) 2018-07-17
US10058566B2 (en) 2018-08-28
JP2019090056A (ja) 2019-06-13
BR112015032849B1 (pt) 2021-09-14
TR201809674T4 (tr) 2018-07-23
EA201690123A1 (ru) 2016-07-29
SG11201510717SA (en) 2016-01-28

Similar Documents

Publication Publication Date Title
DK3334422T3 (da) Anvendelse af cannabidiolsyre i behandling af epilepsi
PL3578547T3 (pl) Pochodne sulfonylomocznika i związki pokrewne oraz ich zastosowanie
DK3043785T3 (da) Anvendelse af r-ketamin og salt deraf som lægemidler
ME03442B (me) Stabilizovani rastvorljivi pre-fuzioni rsv f polipeptidi
PT2852391T (pt) Sistemas para tratamento de infeções pulmonares
DK2970398T3 (da) Præfusions-rsv-f-proteiner og anvendelse deraf
HUE053946T2 (hu) 4'-Fluor-nukleozidok, 4'-fluor-nukleotidok és analógjaik HCV kezelésére
HRP20190318T1 (hr) Farmaceutski ili kozmetički pripravak za liječenje alopecije
EP2994173A4 (en) WOUND HEALING AND TISSUE STRUCTURE
DK2861573T3 (da) Oxathiazin-derivater som antibakterielle og anticancer-stoffer
DK2966079T3 (da) Pyridopyrimidin eller pyridopyrimidinforbindelse, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf
HUE046314T2 (hu) Pirazolopirimidon vagy pirrolotriazon származékok, eljárás ezek elõállítására és gyógyászati alkalmazásaik
PT2859896T (pt) Composições farmacêuticas para o tratamento de distúrbios musculares
HUE14705723T2 (hu) Szubsztituált biciklikus dihidropirimidinonok és alkalmazásuk neutrofil elasztáz aktivitás inhibitoraiként
EP2974360A4 (en) BEHIND THE EAR BEARING HEADPHONES
DK3064491T3 (da) Sulfonamidderivat og medicinsk anvendelse deraf
HUE056434T2 (hu) Glikozaminoglikán vegyület, annak elõállítása és alkalmazása
HUE046113T2 (hu) Terápiás sav ceramidáz készítmények és azok elõállítási és felhasználási eljárásai
EP2999341A4 (en) STABILIZED HYPOCHLORIC ACID SOLUTION AND USE THEREOF
HUE056048T2 (hu) Helyettesített pirimidin vegyületek és SYK inhibitorként való alkalmazásuk
PL2961822T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
FR3002452B1 (fr) Composition dermatologique antimicrobienne topique
DK3041831T3 (da) Alfa-te-saltformer: sammensætninger og anvendelser til behandling af sygdom
PL2988750T5 (pl) Zastosowanie chlorowodorku landilolu w długotrwałym leczeniu tachyarytmii
HUE045192T2 (hu) 6-morfolinil-2-pirazolil-9H-purin származékok és felhasználásuk PI3K inhibitorokként